About Presight Capital
Presight Capital is a venture capital firm founded in 2019. It is primarily based out of West Hollywood, United States. As of Mar 2026, Presight Capital has invested in 40 companies. It primarily invests in Series A round in United States based startups. Its investments are spread across a wide range of sectors from Life Sciences to FinTech and Enterprise Applications. Most recently it participated in the $***** Series E round of Alloy Therapeutics Overall, Presight Capital portfolio has seen 3 unicorns, 3 IPOs and 4 acquisitions including key companies like Qonto, Abcellera Biologics and Alloy Therapeutics. A lot of funds co-invest with Presight Capital, with names like 468 Capital sharing a substantial percentage of its portfolio. Presight Capital has team of 3 people including 1 partners.Key Metrics
Team Members
Portfolio Sectors
Portfolio Locations
Rounds of Entry
Seed, Series A & 5 more
Portfolio IPOs
Portfolio Unicorns
Deals in last 12 months
Presight Capital's List of Top Investments
Presight Capital has a portfolio of 40 companies, including 3 unicorns. Their most notable investments are in Valoreo and Valoreo.Their portfolio spans across United States, United Kingdom, India and 9 more locations. They have invested in Life Sciences, FinTech, Enterprise Applications and 17 other sectors, across stages such as Seed, Series A and 5 more. Here is the list of top investments by Presight Capital:
1. Qonto
Provider of business account, payment cards, and financial management solutions. The company offers tools for customer and supplier invoicing, team expense management, and accounting and bookkeeping. It provides integrations to boost productivity, along with resources such as a resource hub, blog, and finance glossary. The company also provides payment terminals and payment links.
Key facts about Qonto
- Founded Year: 2017
- Location: Paris (France)
- Annual Revenue: €100M - €500M as on Dec 31, 2023
- Valuation: $*****
- Stage: Series D
- Total Funding till date: $717M
- Employee Count: 2,431 as on Aug 31, 2026
- Investors: TCV, HV Capital and 27 Others
- Latest Funding Round: Series D, Apr 21, 2022, $*****
- Highlight: Editors' Pick
2. Syfe
Provider of digital wealth management brokerage and cash savings services. This platform facilitates the management of investment portfolios, the trading of stocks and exchange traded funds, and the allocation of capital into interest bearing savings products. Users access tools for automated asset allocation, rebalancing, and fractional share purchasing across various financial markets. The service enables individuals to maintain diversified holdings and generate passive income through structured investment strategies.
Key facts about Syfe
- Founded Year: 2017
- Location: Singapore (Singapore)
- Annual Revenue: SGD 10M - 50M as on Mar 31, 2025
- Valuation: $*****
- Stage: Series C
- Total Funding till date: $139M
- Employee Count: 241 as on Mar 31, 2026
- Investors: Valar Ventures, Presight Capital and 32 Others
- Latest Funding Round: Series C, Jun 05, 2025, $*****
- Highlight: Editors' Pick
AI-enabled platform for antibodies discovery. The company has developed Celium which is an antibody visualization software and suite of proprietary microfluidic single-cell assays used for antibody screening. The company uses its proprietary repertoire sequencing technologies with functional data from single B cells to annotate immune repertoires. It has also developed its proprietary humanized mouse platform for the development of humanized antibodies.
Key facts about Abcellera Biologics
- Founded Year: 2012
- Location: Vancouver (Canada)
- Annual Revenue: $50M - $100M as on Dec 31, 2025
- Stage: Public
- Total Funding till date: $115M
- Employee Count: 588 as on Aug 31, 2026
- Investors: HTIF, Benson Family Private Equity and 16 Others
- Latest Funding Round: Post IPO, Jun 10, 2021, $*****
- Highlight: Public
Key facts about Alloy Therapeutics
- Founded Year: 2017
- Location: Lexington (United States)
- Valuation: $*****
- Stage: Series E
- Total Funding till date: $157M
- Employee Count: 159 as on Sep 30, 2026
- Investors: Mubadala, Presight Capital and 11 Others
- Latest Funding Round: Series E, Mar 31, 2026, $*****
- Highlight: Editors' Pick
General Fusion is a developer of a magnetized nuclear fusion reactor. The reactor consists of 3 main components, a plasma injector, which converts hydrogen fuel into plasma & holds in a magnetic field; liquid metal wall, which compresses the plasma & captures the energy released; piston array, which collapses liquid metal vortex & shockwave formation by plasma compression. The hot liquid metal is used to operate a heat exchanger by producing power.
Key facts about General Fusion
- Founded Year: 2002
- Location: Burnaby (Canada)
- Stage: Public
- Total Funding till date: $515M
- Employee Count: 152 as on Aug 31, 2026
- Investors: Khazanah Nasional Berhad, GIC and 44 Others
- Latest Funding Round: Conventional Debt, Nov 27, 2025, $*****
- Highlight: Public
Presight Capital's Year-on-Year Investment Trends
Presight Capital has invested in 40 companies over the last 7 years, with an average of 4 new investments annually in the last 5 years. In 2025, it made 7 investments, while as of Mar 2026, it has made 1 investment in this year. Its most recent first time investment was in General Fusion and most recent follow-on round was in Alloy Therapeutics.Year | No. of Investments | ||
|---|---|---|---|
1st Round | Follow-on | Total | |
2026 (YTD) | 0 | 1 | 1 |
2025 | 4 | 3 | 7 |
2024 | 1 | 1 | 2 |
2023 | 2 | 2 | 4 |
2022 | 10 | 3 | 13 |
2021 | 13 | 8 | 21 |
2020 | 7 | 1 | 8 |
2019 | 1 | 0 | 1 |
Presight Capital's Investments by Stage
Presight Capital has made 17 investments in Seed stage with an average round size of $7.19M, 11 investments in Series A stage with an average round size of $39.2M and 6 investments in Series B stage with an average round size of $68.1M.Stage of entry | No. of Investments |
|---|---|
Seed | 17 |
Series A | 11 |
Series B | 6 |
Conventional Debt | 1 |
Series C | 1 |
Others | 2 |
Note: We have considered here, only first round of investments
Presight Capital's Investments by Sector
Presight Capital has a diverse portfolio, with companies operating in the Enterprise Applications, FinTech, High Tech, Life Sciences and Retail. Notably, it has invested in 33 Tech companies, 28 Enterprise (B2B) companies, 11 Consumer (B2C) companies and at least 8 companies focusing on Software.Sector | No. of Investments |
|---|---|
Enterprise Applications | 9 |
FinTech | 9 |
High Tech | 8 |
Life Sciences | 8 |
Retail | 6 |
Others | 35 |
Note: We have considered here, only first round of investments
Presight Capital's Investments by Geography
Presight Capital has made most investments in United States (13), followed by United Kingdom where it has made 5 investments.Country | No. of Investments |
|---|---|
United States | 13 |
United Kingdom | 5 |
India | 4 |
Canada | 3 |
Germany | 3 |
Others | 11 |
Note: We have considered here, only first round of investments
Presight Capital's recent investments
Presight Capital has made 1 investments in 2026 so far - Alloy Therapeutics.Here are the most recent investments by Presight Capital:
Filter this listDate | Company | Location | Round Details | Round Amount | Co-Investors |
|---|---|---|---|---|---|
Mar 31, 2026 | United States | Series E | 5377 | [+8] | |
Oct 16, 2025 | United States | Series B | 2015 | [+4] | |
Sep 10, 2025 | United Kingdom | Series A | 4940 | [+5] | |
Aug 22, 2025 | Canada | Series F | 9098 | ||
Aug 05, 2025 | United Arab Emirates | Series A | 1471 | [+7] |
Unicorns in Presight Capital's Portfolio
Presight Capital has 3 unicorns in its portfolio - Alloy Therapeutics, Qonto and Razor Group. The most recent unicorn in their portfolio is Alloy Therapeutics. It became a unicorn in 2026, 5 years after Presight Capital first invested in it.Here is a list of unicorns in Presight Capital's portfolio:
Tracxn Score | Company | Short Description | Founded year | Sector | Location | Company Stage | First Investment/ Acquisition Details |
|---|---|---|---|---|---|---|---|
69 | Provider of drug discovery services | 2017 | Lexington | Series E | irbqlnl | ||
82 | Provider of business account, payment cards, and financial management solutions | 2017 | Paris | Series D | jdvenex | ||
52 | Platform acquiring Amazon FBA brands | 2020 | Berlin | Series D | u{dzmk{ |
IPOs and Publicly Listed companies in Presight Capital's Portfolio
3 of Presight Capital's portfolio companies have become public. General Fusion got listed on the National Association of Securities Dealers Automated Quotations (NASDAQ), in Jul 2026 and Sensei Biotherapeutics got listed on the National Association of Securities Dealers Automated Quotations (NASDAQ) at marketcap of $562M.Here are Presight Capital's portfolio companies that went public:
Company | IPO Date | First Invested on | First Round of Investment | Round Size |
|---|---|---|---|---|
Jul 13, 2026 | Aug 22, 2025 | Series F | 8671 | |
Feb 04, 2021 | Oct 07, 2020 | Unattributed | 4037 | |
Dec 11, 2020 | Mar 23, 2020 | Series B | 5853 |
Acquired companies in Presight Capital's Portfolio
4 companies from Presight Capital's portfolio have been acquired. The most recent acquisition was Denario in Aug 2023 by PandaDoc for $*****.Here are Presight Capital's portfolio companies that got acquired most recently:
Company | Acquisition Date | First Invested on | First Round of Investment | Round Size |
|---|---|---|---|---|
Aug 28, 2023 | Jan 10, 2022 | Seed | 9480 | |
Dec 22, 2022 | Feb 16, 2021 | Seed | 9785 | |
Jul 22, 2022 | Jul 07, 2020 | Series B | 7094 | |
Aug 27, 2018 | May 18, 2022 | Seed | 4434 |
Team profile of Presight Capital
Presight Capital has a team of 3 members located in United Kingdom. Presight Capital's team does not sit on the board of any company as of now.Co-investors of Presight Capital
Over the past 7 years, 366 investors have co-invested in Presight Capital's portfolio companies. This includes funds and angels.
- Invested before Presight Capital: DCVC, Peter Thiel and 105 others have invested in rounds before Presight Capital. There are 2 companies where DCVC has invested before Presight Capital and 2 companies where Peter Thiel has invested before Presight Capital.
- Top Co-investors of Presight Capital: 146 investors entered a company along with Presight Capital. These include investors like 468 Capital (10 companies).
- Invested after Presight Capital: A total of 113 investors have invested in Presight Capital's portfolio after their investments. Top Investors include Peter Thiel (2 companies), Thiel Bio (2 companies) and HHS (2 companies).
Recent News related to Presight Capital
•
•
Peter Thiel-backed Peptilogics raises $78M for prosthetic joint infection programEndpoints•Oct 16, 2025•Peptilogics, Presight Capital, Founders Fund, Beyond Venture Partners and 5 others
•
TERN Group secures €20.4M to address healthcare staff shortagesSilicon Canals•Sep 10, 2025•TERN, Notion, RTP Global, DST Global and 5 others
•
General Fusion closes oversubscribed US$22 million financing; welcomes new Board membersBenzinga•Aug 21, 2025•Thistledown Capital, Jimco, General Fusion, Pender and 8 others
•
•
Needle Secures $2.2 Million in Seed FundingStartup Rise EU•Mar 03, 2025•Needle, 468 Capital, Presight Capital, Tuft & Needle and 5 others
•
UAE Presight launches next-gen data, AI platform to future-proof enterprise AI adoptionTahawulTech.com•Feb 27, 2025•Presight Capital
•
Presight Achieved a 24.3% Revenue Increase to Record AED 2.2 billion in 2024Channel Post Middle East & Africa•Feb 11, 2025•Presight Capital
•
South Africa's FARO secures $6 million to make fashion affordableTechpoint.Africa•Jan 15, 2025•FARO Africa, Presight Capital, Venture Garage, Faro and 1 other
•
Arnault-backed Razor buys Perch in Amazon ‘aggregator’ shakeoutFashion Network•Mar 04, 2024•Amazon, Razor Group, Perch, L Catterton and 14 others
